Skip to content
10-Q

Quarterly Report

BioCrude Technologies USA, Inc.

0001731122-22-000853

← back to feed
Filed
May 10, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · Mar 31, 2022 50.72M sh
Total Liabilities Q1 2022 · Mar 31, 2022 $198.01K
Total Liabilities Q1 2022 · Dec 31, 2021 $196.48K
Total Assets Q1 2022 · Mar 31, 2022 $20.16K
Total Assets Q1 2022 · Dec 31, 2021 $22.63K
Net Income Q1 2022 · Dec 31, 2021 −$431.46K
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$165.1K
Sga Expense Q1 2022 · Mar 31, 2021 $162.7K
Operating Income Q1 2022 · Mar 31, 2021 −$162.7K